• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种逐步改进基于脂质体的纳米材料临床转化的方法,重点关注先天免疫和炎症反应。

A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses.

作者信息

Della Camera Giacomo, Lipsa Dorelia, Mehn Dora, Italiani Paola, Boraschi Diana, Gioria Sabrina

机构信息

European Commission, Joint Research Centre, 21027 Ispra, Italy.

Institute of Biochemistry and Cell Biology, National Research Council, 80131 Naples, Italy.

出版信息

Int J Mol Sci. 2021 Jan 15;22(2):820. doi: 10.3390/ijms22020820.

DOI:10.3390/ijms22020820
PMID:33467541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7830677/
Abstract

This study aims to provide guidelines to design and perform a robust and reliable physical-chemical characterization of liposome-based nanomaterials, and to support method development with a specific focus on their inflammation-inducing potential. Out of eight differently functionalized liposomes selected as "case-studies", three passed the physical-chemical characterization ( in terms of size-distribution, homogeneity and stability) and the screening for bacterial contamination (sterility and apyrogenicity). Although all three were non-cytotoxic when tested in vitro, they showed a different capacity to activate human blood cells. HSPC/CHOL-coated liposomes elicited the production of several inflammation-related cytokines, while DPPC/CHOL- or DSPC/CHOL-functionalized liposomes did not. This work underlines the need for accurate characterization at multiple levels and the use of reliable in vitro methods, in order to obtain a realistic assessment of liposome-induced human inflammatory response, as a fundamental requirement of nanosafety regulations.

摘要

本研究旨在提供指导方针,以设计并开展基于脂质体的纳米材料稳健且可靠的物理化学表征,并支持方法开发,特别关注其诱导炎症的潜力。在选为“案例研究”的八种不同功能化脂质体中,三种通过了物理化学表征(在尺寸分布、均一性和稳定性方面)以及细菌污染筛查(无菌性和无热原性)。尽管这三种在体外测试时均无细胞毒性,但它们激活人类血细胞的能力有所不同。HSPC/CHOL包被的脂质体引发了几种炎症相关细胞因子的产生,而DPPC/CHOL或DSPC/CHOL功能化的脂质体则没有。这项工作强调了在多个层面进行准确表征以及使用可靠体外方法的必要性,以便对脂质体诱导的人类炎症反应进行现实评估,这是纳米安全法规的一项基本要求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/b7d1e78ab01d/ijms-22-00820-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/a1b8d8c68838/ijms-22-00820-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/af6bf072c1c7/ijms-22-00820-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/f5eaf61c2a32/ijms-22-00820-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/cd490c03cb7e/ijms-22-00820-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/0065bff1113a/ijms-22-00820-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/b6ac5103442d/ijms-22-00820-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/f4fa0a84ed70/ijms-22-00820-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/b7d1e78ab01d/ijms-22-00820-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/a1b8d8c68838/ijms-22-00820-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/af6bf072c1c7/ijms-22-00820-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/f5eaf61c2a32/ijms-22-00820-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/cd490c03cb7e/ijms-22-00820-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/0065bff1113a/ijms-22-00820-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/b6ac5103442d/ijms-22-00820-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/f4fa0a84ed70/ijms-22-00820-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e006/7830677/b7d1e78ab01d/ijms-22-00820-g008.jpg

相似文献

1
A Step-by-Step Approach to Improve Clinical Translation of Liposome-Based Nanomaterials, a Focus on Innate Immune and Inflammatory Responses.一种逐步改进基于脂质体的纳米材料临床转化的方法,重点关注先天免疫和炎症反应。
Int J Mol Sci. 2021 Jan 15;22(2):820. doi: 10.3390/ijms22020820.
2
HEPC-based liposomes trigger cytokine release from peripheral blood cells: effects of liposomal size, dose and lipid composition.基于肝细胞生长因子的脂质体引发外周血细胞释放细胞因子:脂质体大小、剂量和脂质组成的影响。
Int J Pharm. 2002 Apr 2;236(1-2):125-33. doi: 10.1016/s0378-5173(02)00026-1.
3
Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells.基于乙醇的紫杉醇前体脂质体传递系统,用于体外对抗脑癌细胞。
J Liposome Res. 2018 Mar;28(1):74-85. doi: 10.1080/08982104.2016.1259628. Epub 2016 Dec 14.
4
Application of liposomes for development of oral vaccines: study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization.脂质体在口服疫苗研发中的应用:脂质体的体外稳定性及口服免疫后对脂质体相关抗原的抗体反应研究。
J Vet Med Sci. 1997 Dec;59(12):1109-14. doi: 10.1292/jvms.59.1109.
5
Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes.脂质组成和制备条件对载吉西他滨脂质体的物理化学性质、工艺参数及体外生物活性的影响
Curr Drug Deliv. 2007 Jan;4(1):89-101. doi: 10.2174/156720107779314749.
6
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate.利用QS-21皂苷和鲎变形细胞溶解物检测脂质体胆固醇和单磷酰脂质A。
Biochim Biophys Acta. 2015 Mar;1848(3):775-80. doi: 10.1016/j.bbamem.2014.12.005. Epub 2014 Dec 12.
7
Expression of luciferase plasmid (pCMVLuc) entrapped in DPPC/cholesterol/DDAB liposomes in HeLa cell lines.在 HeLa 细胞系中表达被 DPPC/胆固醇/DDAB 脂质体包封的荧光素酶质粒 (pCMVLuc)。
J Liposome Res. 2009;19(2):131-40. doi: 10.1080/08982100802642457.
8
Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice.鼻腔接种肺炎球菌表面蛋白 A 联合由 DOTAP 和 DC-chol 组成的阳离子脂质体可在小鼠体内诱导针对肺炎链球菌感染的抗原介导的保护性免疫。
Int Immunopharmacol. 2018 Aug;61:385-393. doi: 10.1016/j.intimp.2018.06.027. Epub 2018 Jun 23.
9
Fusogenic pH sensitive liposomal formulation for rapamycin: improvement of antiproliferative effect.用于雷帕霉素的促融合pH敏感脂质体制剂:抗增殖效果的改善
Pharm Biol. 2014 Jul;52(7):848-54. doi: 10.3109/13880209.2013.871640. Epub 2014 Feb 7.
10
The immune-stimulation capacity of liposome-treated red blood cells.脂质体处理的红细胞的免疫刺激能力。
J Liposome Res. 2018 Sep;28(3):173-181. doi: 10.1080/08982104.2017.1295991. Epub 2017 Mar 9.

引用本文的文献

1
Differences in Physico-Chemical Properties and Immunological Response in Nanosimilar Complex Drugs: The Case of Liposomal Doxorubicin.纳米类似复杂药物中物理化学性质和免疫反应的差异:以脂质体多柔比星为例。
Int J Mol Sci. 2023 Sep 2;24(17):13612. doi: 10.3390/ijms241713612.
2
Inter-Individual Variations: A Challenge for the Standardisation of Complement Activation Assays.个体间差异:补体激活检测标准化的挑战。
Int J Nanomedicine. 2023 Feb 11;18:711-720. doi: 10.2147/IJN.S384184. eCollection 2023.
3
The SARS-CoV-2 Nucleoprotein Induces Innate Memory in Human Monocytes.

本文引用的文献

1
Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory.不对称流场流分离技术用于测量纳米药物的粒径、载药量和(不)稳定性。欧盟纳米药物表征实验室和美国国家癌症研究所-纳米技术表征实验室的联合观点。
J Chromatogr A. 2021 Jan 4;1635:461767. doi: 10.1016/j.chroma.2020.461767. Epub 2020 Nov 27.
2
Immunological and Toxicological Considerations for the Design of Liposomes.脂质体设计的免疫学和毒理学考量
Nanomaterials (Basel). 2020 Jan 22;10(2):190. doi: 10.3390/nano10020190.
3
SARS-CoV-2 核衣壳蛋白诱导人单核细胞固有记忆。
Front Immunol. 2022 Jul 19;13:963627. doi: 10.3389/fimmu.2022.963627. eCollection 2022.
4
Comparative Study on Curcumin Loaded in Golden Pompano () Head Phospholipid and Soybean Lecithin Liposomes: Preparation, Characteristics and Anti-Inflammatory Properties.姜黄素载金黄鯵鱼头磷脂和大豆卵磷脂脂质体的比较研究:制备、特性和抗炎性质。
Molecules. 2021 Apr 16;26(8):2328. doi: 10.3390/molecules26082328.
Sizing up the Next Generation of Nanomedicines.
评估下一代纳米药物。
Pharm Res. 2019 Dec 11;37(1):6. doi: 10.1007/s11095-019-2736-y.
4
Immunotoxicity Considerations for Next Generation Cancer Nanomedicines.下一代癌症纳米药物的免疫毒性考量
Adv Sci (Weinh). 2019 Aug 1;6(19):1900133. doi: 10.1002/advs.201900133. eCollection 2019 Oct 2.
5
Nanoparticles in the clinic: An update.临床中的纳米颗粒:最新进展
Bioeng Transl Med. 2019 Sep 5;4(3):e10143. doi: 10.1002/btm2.10143. eCollection 2019 Sep.
6
The Interplay Between Blood Proteins, Complement, and Macrophages on Nanomedicine Performance and Responses.纳米医学性能与反应中血液蛋白、补体与巨噬细胞的相互作用。
J Pharmacol Exp Ther. 2019 Sep;370(3):581-592. doi: 10.1124/jpet.119.258012. Epub 2019 Apr 2.
7
Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity.测量纳米药物的粒径分布,EUNCL 和 NCI-NCL 的联合观点。一种结合正交测量和逐步增加复杂性的方法。
J Control Release. 2019 Apr 10;299:31-43. doi: 10.1016/j.jconrel.2019.02.030. Epub 2019 Feb 21.
8
Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles.通过不对称流场流分离测量粒径分布:脂质纳米粒临床前特征分析的有力方法。
Mol Pharm. 2019 Feb 4;16(2):756-767. doi: 10.1021/acs.molpharmaceut.8b01033. Epub 2019 Jan 16.
9
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia.FDA 批准概要:(柔红霉素和阿糖胞苷)脂质体注射剂用于治疗高危急性髓系白血病的成人患者。
Clin Cancer Res. 2019 May 1;25(9):2685-2690. doi: 10.1158/1078-0432.CCR-18-2990. Epub 2018 Dec 12.
10
Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides.阳离子脂质体:一种用于理化性质多样的抗原肽的灵活疫苗传递系统。
Pharm Res. 2018 Sep 12;35(11):207. doi: 10.1007/s11095-018-2490-6.